A Phase II Study of AS1411 in Renal Cell Carcinoma

Status:
Unknown status

Trial end date:
2010-03-01

Target enrollment:

Participant gender:

The aim of this study is to evaluate the efficacy of AS1411 in patients with Metastatic Renal Cell Carcinoma

Phase 2

Antisoma Research